RxDoctor Payments Data

Joshua Hirsch

Houston, TXNPI 1528563566

Payments from drug & device makers

$15,191in general payments, 2019–2025

Across 186 payments — averaging $81.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Medtronic$5K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$1K
  • Amgen$197
  • Abiomed$152
  • plus $258 from 5 others

What the payments were for

  • Grants$2,50016%
  • Travel & lodging$4,63431%
  • Food & beverage$6,95946%
  • Education$1,0987%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott72$5,639
Medtronic43$5,345
Boston Scientific32$2,245
Biosense Webster, Inc.25$1,355
Amgen5$197
Abiomed2$152
Penumbra, Inc.1$129
Boehringer Ingelheim3$46
Bridgebio Pharma, Inc.1$42
Novartis1$26
CMP Pharma, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$12,818
Atorvastatin Calcium15$184
Lisinopril12$39

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →